Medical Devices Investors & VC Firms in United States
1104 firms in this list, with a median first check of $500K. 275 of them lead rounds. Generated from verified public data and updated continuously.
Rock Springs Capital
BaltimoreLate Stage
13 people
BioHealth Innovation, Inc.
Rockville
21 people
Life Sciences Greenhouse Investments
HarrisburgPre-Seed–Series B$250K – $1.5M
12 people
Micron Ventures
BoisePre-Seed–Series A
12 people
MBX Capital
ClaymontPre-Seed–Series A$250K – $2.5M
5 people
Okapi Venture Capital
Newport BeachSeed–Series A$750K – $3M
5 people
SyndicateRoom
CambridgePre-Seed–Series A
13 people
Lewis & Clark Ventures
St. LouisSeed–Series A$2M – $3M
12 people
MemorialCare Innovation Fund
Long BeachSeed–Growth
12 people
Bioventures Investors
WestboroughSeed–Growth$15M – $100M
16 people
PsyMed Ventures
BerkeleyPre-Seed–Series A
13 people
Texas HALO Fund
AustinSeed–Series A
5 people
Scientia Ventures
New YorkSeries A–Series B
13 people
Star51 Capital
New York
16 people
BrightEdge
AtlantaPre-Seed–Late Stage
15 people
Iaso Ventures
CambridgeSeed–Series A
12 people
MedMountain Ventures
Salt Lake CitySeed–Series A$500K – $5M
9 people
Research Corporation Technologies
TucsonSeed–Series A
12 people
True Wealth Ventures
AustinSeed–Series A$1M
10 people
Avalon Ventures Management, Llc
La JollaPre-Seed–Series A$500K – $10M
9 people
Concord Health Partners
SummitLate Stage
15 people
Forward Venture Capital
DenverSeed–Series A$50K – $500K
2 people
Clarevia Ventures
MadisonSeed–Series A$250K – $2.5M
13 people
Intuitive Ventures
SunnyvaleSeed–Series A
16 people
Related lists
Investors & VC Firms in North America (13286)Investors & VC Firms in United States (12284)Investors & VC Firms in Europe (6052)AI & Machine Learning Investors & VC Firms (5303)Investors & VC Firms in Global (5278)Fintech Investors & VC Firms (5112)Healthtech Investors & VC Firms (4639)SaaS Investors & VC Firms (4498)Enterprise Software Investors & VC Firms (4394)Crypto & Web3 Investors & VC Firms (4130)
Data sourced from public filings and firms' own websites — see our methodology.






























































































